Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
Chen Yang(Heidelberg University), Haigang Geng(Shanghai Jiao Tong University), Xupeng Yang(Ministry of Education), Shuyi Ji(Fudan University), Zhicheng Liu(Tongji Hospital), Hao Feng(Shanghai Jiao Tong University), Qian Li(Shanghai Jiao Tong University), Tangansu Zhang(Union Hospital), Si‐Si Zhang(Shanghai Jiao Tong University), Xuhui Ma(Shanghai Jiao Tong University), Chuchen Zhu(Shanghai Jiao Tong University), Nuo Xu(Shanghai Jiao Tong University), Yuhan Xia(Shanghai Jiao Tong University), Yan Li(Sun Yat-sen University), Hongye Wang(Shanghai Jiao Tong University), Chune Yu(Shanghai Jiao Tong University), Shangce Du(German Cancer Research Center), Beiping Miao(German Cancer Research Center), Lei Xu(Tongji Hospital), Hui Wang(Shanghai Jiao Tong University), Ying Cao(Shanghai Jiao Tong University), Botai Li(Shanghai Jiao Tong University), Lili Zhu(Shanghai Jiao Tong University), Xiangyu Tang(Shanghai Jiao Tong University), Haoyu Zhang(Shanghai Jiao Tong University), Chunchao Zhu(Shanghai Jiao Tong University), Zhao Huang(Tongji Hospital), Chao Leng(Tongji Hospital), Haiyan Hu(Shanghai Jiao Tong University), Xiaoping Chen(Tongji Hospital), Shengxian Yuan(Second Military Medical University), Guang‐Zhi Jin(Shanghai Jiao Tong University), René Bernards(The Netherlands Cancer Institute), Chong Sun(German Cancer Research Center), Quan Zheng(Shanghai Jiao Tong University), Wenxin Qin(Renji Hospital), Qiang Gao(Fudan University), Cun Wang(Renji Hospital)
Cited by 66